|
Report Date : |
25.06.2014 |
IDENTIFICATION DETAILS
|
Name : |
MULTILAB INDUSTRIA E COMERCIO DE PRODUTOS FARMACEUTICOS LTDA |
|
|
|
|
Registered Office : |
Rodovia Rs 401 - Km 30 - Nº. 1009 - São Jerônimo 96700-000 - São Jerônimo/RS |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
30.09.2012 |
|
|
|
|
Date of Incorporation : |
01.08.1988 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Engaged in manufacturing and trading of Medicines. |
|
|
|
|
No. of Employees : |
741 |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BRAZIL - ECONOMIC OVERVIEW
Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% in 2011, and 1.3% in 2012. Unemployment is at historic lows and Brazil's traditionally high level of income inequality has declined for each of the last 14 years. Brazil's historically high interest rates have made it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchange markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint. In an effort to boost growth, in 2012 the administration implemented a somewhat more expansionary monetary policy that has failed to stimulate much growth.
Source : CIA
MULTILAB INDUSTRIA
E COMERCIO DE PRODUTOS FARMACEUTICOS LTDA
|
MAIN ADDRESS: |
RODOVIA RS 401 - KM 30 - Nº. 1009 - SÃO JERÔNIMO |
|
ZIP CODE/CITY: |
96700-000 - SÃO JERÔNIMO/RS |
|
|
|
|
PHONE: |
51 3055-9000 |
|
FAX: |
51 3055-9068 |
|
E-MAIL: |
|
|
WEB SITE: |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
RUA MARIANO DE MATOS, 742 |
|
ZIP CODE/CITY: |
90880-250 PORTO ALEGRE/RS |
|
|
|
|
ADDRESS: |
AVENIDA INSUTRIAL BELGRAF, 250 CENTRO |
|
ZIP CODE/CITY: |
92990-000 ELDORADO SUL SUL/RS |
|
PHONE: |
51 3230-4043 |
|
MAIN ACTIVITIES: |
|
MANUFACTURE AND TRADE OF MEDICINES. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
01/08/1988 |
|
REGISTER DATE: |
04/08/1988 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
92.265.552/0001-40 |
|
STATE REGISTER: |
121/0050568 |
|
|
|
|
SHARE CAPITAL: |
R$ 41.570.000,00 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
GILES RICHARD PLATFORD |
MANAGER |
|
JUN CELSO EGUTI |
MANAGER |
|
THE MANAGERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
TAKEDA FARMACÊUTICA BRASIL LTDA |
100% |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
|
|
|
INDUSTRIA FARMACEUTICA MILIAN LTDA |
|
|
THE SUBJECT WAS ESTABLISHED ON AUGUST 01, 1988 TO BE ENGAGED IN THE SAID
LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL
SCENE REPORTED HEREIN. TRADE NAME: "MULTILAB". PARTNERS: GENESIO CERVO: BRAZILIAN, DIVORCED, HOLDER OF DOCUMENTS RG 100292632
SSP/RS, CPF 140.389.860-04, RESIDENTIAL ADDRESS AT PRAÇA SÃO CAETANO 90 CASA
05, PORTO ALEGRE/RS; REJANE TEREZINHA GOBBI: BRAZILIAN, SINGLE, HOLDER OF DOCUMENTS RG
7032924537 SSP/RS, CPF 503.542.130-91, RESIDENTIAL ADDRESS AT PRAÇA SÃO
CAETANO 90 CASA 05, PORTO ALEGRE/RS. REMARKS: ACCORDING TO AMENDMENT TO THE ARTICLES OF INCORPORATION DATED OF JULY
02, 2012 (AND PURCHASE AND SALE OF SHARES CONTRACT DATED OF MAY 25, 2012) THE
PARTNERS GENÉSIO CERVO AND TERESINHA GOBBI, WITHDREW FROM THE PARTNERSHIP AND
TRANSFERRED THE TOTALITY OF SHARES TO TAKEDA FARMACÊUTICA BRASIL LTDA., WHICH
BELONGS TO THE TAKEDA GROUP FROM JAPAN. OUTSIDE SOURCES STATED THAT
ACQUISITION AMOUNTED TO R$ 540 MILLIONS. FURTHER, IN 2011 THE TAKEDA GROUP
ALSO ACQUIRED NYCOMED FROM SWITZERLAND FOR THE AMOUNT OF 14 BILLION. FURTHER DETAILS ARE SO FAR NOT KNOWN. |
|
PUBLIC
INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
|
GENERAL BALANCE SHEETS AS OF 30/09/2012, 31/12/2011 AND 31/12/2010. |
|
( FIGURES ARE IN REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
30/09/2012 |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS |
15.217.433,75 |
2.995.301,73 |
1.486.139,40 |
|
CLIENTS |
32.013.438,25 |
36.785.546,71 |
27.766.170,91 |
|
INVENTORY |
36.973.351,18 |
28.480.717,70 |
32.653.857,81 |
|
RECOVERABLE TAXES |
14.185.826,29 |
13.960.052,80 |
8.760.100,75 |
|
ADVANCES |
79.341,58 |
59.425,62 |
31.294,38 |
|
OTHER CREDITS |
939.032,88 |
957.943,54 |
703.362,14 |
|
PRE PAID EXPENSES |
767.068,42 |
409.516,27 |
1.640.615,02 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT ASSETS |
100.175.492,35 |
83.648.504,37 |
73.041.540,41 |
|
LONG-TERM
RECEIVABLES: |
|
|
|
|
|
|
|
|
|
JUDICIAL DEPOSITS |
2.665.983,48 |
3.127.069,20 |
2.945.345,38 |
|
DEFERRED TAXES |
10.609.045,72 |
890.985,98 |
|
|
PUBLIC DEBTS |
|
7.262.460,83 |
9.549.710,88 |
|
INTERCOMPANY CREDITS |
346.397,14 |
1.700.287,34 |
1.409.490,14 |
|
OTHER CREDITS |
|
695.826,58 |
7.590.533,02 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG-TERM RECEIVABLES |
13.621.426,34 |
13.676.629,93 |
21.495.079,42 |
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
INVESTMENTS |
1.549,29 |
1.549,29 |
1.549,29 |
|
FIXED ASSETS |
61.876.459,18 |
59.488.525,71 |
47.870.681,11 |
|
INTANGIBLE |
31.847.224,94 |
26.425.567,76 |
22.206.119,34 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL FIXED ASSETS |
93.725.233,41 |
85.915.642,76 |
70.078.349,74 |
|
|
================ |
================ |
================ |
|
TOTAL ASSETS |
207.522.152,10 |
183.240.777,06 |
164.614.969,57 |
|
LIABILITIES: |
|
|
|
|
CURRENT: |
30/09/2012 |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
SUPPLIERS |
8.488.418,92 |
5.785.967,73 |
5.479.897,43 |
|
LOANS AND FINANCING |
|
34.264.627,27 |
33.561.142,56 |
|
SOCIAL / LABOR OBLIGATIONS |
5.388.257,13 |
4.830.069,23 |
8.056.652,10 |
|
TAX LIABILITIES |
6.304.389,52 |
6.253.034,55 |
7.972.745,15 |
|
DEBT WITH RELATED PARTIES |
|
|
562.332,57 |
|
DEFERRED TAXES |
547.878,46 |
701.504,04 |
906.382,35 |
|
ACCOUNTS PAYABLE |
|
3.021.018,14 |
2.694.551,53 |
|
OTHER |
6.087.320,73 |
124.256,65 |
2.272.065,04 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT LIABILITIES |
26.816.264,76 |
54.980.477,61 |
61.505.768,73 |
|
LONG TERM LIABILITIES:
|
|
|
|
|
|
|
|
|
|
INSTALLMENTS TAXES PAYABLE |
17.175.321,20 |
789.500,35 |
1.793.556,86 |
|
RELATED COMPANIES |
95.713.965,71 |
13.126.095,49 |
1.743.093,18 |
|
LOANS AND FINANCING |
|
24.524.705,34 |
20.726.307,28 |
|
JUDICIAL DEPOSITS |
2.531.722,71 |
|
|
|
PROVISIONS |
23.072.421,76 |
386.363,45 |
1.526.145,76 |
|
DEFERRED TAXES |
|
5.779.086,71 |
4.573.275,61 |
|
TAX INCENTIVES |
|
12.621.319,61 |
11.711.609,43 |
|
DEFERRED REVENUE |
11.607.287,02 |
8.066.021,39 |
1.875.470,59 |
|
OTHER |
42.319,22 |
|
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG TERM LIABILITIES |
150.143.037,62 |
65.293.092,34 |
43.949.458,71 |
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
41.570.000,00 |
41.570.000,00 |
2.600.000,00 |
|
CAPITAL RESERVES |
7.162.115,97 |
6.836.971,95 |
6.439.757,11 |
|
ACCRUED PROFIT (LOSS) |
|
11.222.709,90 |
46.562.802,20 |
|
OTHER |
|
3.337.525,26 |
3.557.183,22 |
|
OTHER COMPREHENSIVE INCOME |
3.172.802,34 |
|
|
|
PROFIT RESERVES |
1.345.563,00 |
|
|
|
PROFIT (LOSS) OF PERIOD |
-22.687.631,59 |
|
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL NET EQUITY |
30.562.849,72 |
62.967.207,11 |
59.159.742,53 |
|
|
================ |
================ |
================ |
|
TOTAL LIABILITIES |
207.522.152,10 |
183.240.777,06 |
164.614.969,97 |
|
PROFIT AND LOSS ACCOUNTS AS OF 30/09/2012, 31/12/2011 AND 31/12/2010. |
|
( FIGURES ARE IN REAIS ). |
|
|
30/09/2012 |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
GROSS SALES |
116.425.960,34 |
164.068.207,98 |
146.531.136,25 |
|
(-) TAXES ON SALES |
16.983.881,90 |
24.036.044,91 |
20.961.986,67 |
|
|
---------------- |
---------------- |
---------------- |
|
NET SALES |
99.442.078,44 |
140.032.163,07 |
125.569.149,58 |
|
(-) COST OF SOLD GOODS |
56.608.009,00 |
80.033.737,48 |
71.997.712,94 |
|
|
---------------- |
---------------- |
---------------- |
|
GROSS PROFIT |
42.834.069,44 |
59.998.425,59 |
53.571.436,64 |
|
OPERATING REVENUE (EXPENSE) |
-56.373.237,83 |
-33.976.305,02 |
-29.768.528,59 |
|
FINANCIAL REVENUE(EXPENSE) |
-9.148.463,20 |
-11.113.408,93 |
-6.349.293,70 |
|
|
---------------- |
---------------- |
---------------- |
|
OPERATIONAL PROFIT (LOSS) |
-22.687.631,59 |
14.908.711,64 |
17.453.614,35 |
|
CONTRIBUTION/INCOME TAX |
|
-1.553.000,12 |
-3.559.576,24 |
|
INTERESTS ON OWN CAPITAL |
|
3.175.099,09 |
2.495.907,44 |
|
|
---------------- |
---------------- |
---------------- |
|
NET PROFIT (LOSS) |
-22.687.631,59 |
16.530.810,61 |
16.389.945,55 |
|
RATIOS: |
30/09/2012 |
31/12/2011 |
31/12/2010 |
|
QUICK RATIO |
2,36 |
|
1,00 |
|
,66 |
|
|
CURRENT RATIO |
3,74 |
|
1,52 |
|
1,19 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
3,11 |
TIMES |
3,81 |
TIMES |
4,52 |
TIMES |
|
DAYS' SALES IN RECEIVABLES |
86,92 |
DAYS |
94,57 |
DAYS |
79,60 |
DAYS |
|
INVENTORY TURNOVER |
1,53 |
TIMES |
2,81 |
TIMES |
2,20 |
TIMES |
|
ACCOUNTS PAYABLE PERIOD |
40,49 |
DAYS |
26,03 |
DAYS |
27,40 |
DAYS |
|
RETURN ON ASSETS |
,48 |
TIMES |
,76 |
TIMES |
,76 |
TIMES |
|
SALES TURNOVER ON NET EQUITY |
3,25 |
TIMES |
2,22 |
TIMES |
2,12 |
TIMES |
|
NET WORTH TIE-UP |
2,02 |
|
,94 |
|
,81 |
|
|
INDEBTEDNESS |
5,79 |
|
1,91 |
|
1,78 |
|
|
EQUITY RATIO |
14,73 |
% |
34,36 |
% |
35,94 |
% |
|
WORKING CAPITAL RATIO |
273,56 |
% |
52,14 |
% |
18,76 |
% |
|
GENERAL SOLVENCY |
1,17 |
|
1,52 |
|
1,56 |
|
|
RETURN ON NET EQUITY |
-74,23 |
% |
26,25 |
% |
27,70 |
% |
|
RETURN ON SALES (PROFIT MARGIN) |
-22,81 |
% |
11,81 |
% |
13,05 |
% |
|
GROSS PROFIT MARGIN |
43,07 |
% |
42,85 |
% |
42,66 |
% |
|
OPERATIONAL RESULT |
-22,81 |
% |
10,65 |
% |
13,90 |
% |
|
SALES TURNOVER ON LIABILITIES |
3,71 |
TIMES |
2,55 |
TIMES |
2,04 |
TIMES |
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 2,03 |
- OFFICIAL RATE ON 01/11/2012 |
|
US$ 1,00 = R$ 2,03 |
- OFFICIAL RATE ON 30/09/2012 |
|
US$ 1,00 = R$ 1,87 |
- OFFICIAL RATE ON 31/12/2011 |
|
US$ 1,00 = R$ 1,66 |
- OFFICIAL RATE ON 31/12/2010 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE ANNUAL FIGURES FOR 2011 SHOW A SATISFACTORY FINANCIAL STANDING.
THE LEVEL OF INDEBTEDNESS WAS HIGH AND WAS MOSTLY COMPRISED BY LONG TERM
LIABILITIES. ON THE OTHER HAND, IT HAD GOOD LIQUIDITY AND POSITIVE WORKING
CAPITAL, CONSIDERED SUFFICIENT TO FACE THE SHORT TERM DEBTS. IT ALSO SHOWED
GROWING SALES AND PROFITABILITY. THE INTERIM FIGURES FOR SEPTEMBER 2012 SHOW A SIGNIFICANT INCREASE IN
THE LEVEL OF INDEBTEDNESS. NEVERTHELESS, THE LIQUIDITY ALSO INCREASED. IT
ALSO SHOWS DOWNWARD SALES TREND AND NEGATIVE RESULT DUE TO THE HIGH OPERATING
EXPENSES. REMARKS: ACCORDING TO THE COMPANY IT FACED HIGH LOSS IN SEPTEMBER 2012 DUE TO
R$ 20 MILLIONS IN PROVISIONS. THEY STATED THAT THEY COMPANY IS CARRYING OUT
ADJUSTMENTS AND SUCH PROVISIONS WILL NO LONGER BE USED. |
|
REAL ESTATE: |
OWNED PREMISES ARE VALUED AT R$
14.547.933,64
|
VEHICLES: |
OWNED VEHICLES ARE VALUED AT R$
79.452,47
|
MACHINES: |
OWNED MACHINES AND EQUIPMENTS
ARE VALUED AT R$ 12.527.895,24
|
THE COMPANY CONTRACTS INSURANCE OVER ITS OPERATIONAL ASSETS IN AMOUNTS
CONSIDERED ADEQUATE BY ITS MANAGEMENT |
|
|
BRANCH/PHONE: |
|
|
BANCO DO BRASIL S/A |
3418-5 / 51 3214-7676 |
|
|
BANCO BANRISUL S/A |
047 / 51 3223-1799 |
|
|
BANCO SAFRA S/A |
51 2131-3746 |
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW
PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). |
|
SUBJECT IS ENGAGED IN THE MANUFACTURE AND TRADE OF MEDICINES. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
ITALY, GERMANY, MEXICO, CANADA AND INDIA. |
EXPORTS TO:
|
DOES NOT EXPORT. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
PHONE: |
|
CERVOSUL DISTRIB MEDICAMENTOS LTDA |
|
51 3230-4000 |
|
DISTRIBUIDORA BRINGEL LTDA |
|
92 2126-4000 |
|
DIVAMED DISTR IRMÃOS VALOTTO MEDIC |
|
14 3405-5500 |
|
EMEFARMA RIO REPRESENTAÇÕES LTDA |
|
21 2187-8900 |
|
GALINDO DIT E REPRES LTDA (PE) |
|
81 3343-8999 |
|
GAUCH FARMA MEDICAMENTOS LTDA |
|
51 3382-2200 |
|
GERRAFARMA DISTR E REPRES LTDA |
|
86 3221-2359 |
|
GLOBO FARMA DISTRIBUIDORA LTDA |
|
75 3603-7800 |
|
MS FARMA COMERCIAL LTDA |
|
75 3224-0228 |
|
NORTEFARMA COMÉRCIO LTDA |
|
84 3661-2393 |
|
PRODIET FARMACEUTICA S/A |
|
41 2169-4848 |
|
TAPAJOS DISTR DE PROD FARMAC LTDA |
|
92 2123-4000 |
|
TOTAL COMERCIO E REPRESENTAÇÕES LTDA |
|
85 3311-2350 |
|
STAFF: |
|
|
|
THE COMPANY HAS: 741 EMPLOYEE(S) |
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1988. SO FAR
IT HAS A CLEAR TRADE HISTORY AND NO PAYMENT PROBLEMS ARE NOTED. THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE
SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS
ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
PHONE: |
|
AB FARM QUIMICA LTDA |
|
62 3316-3420 |
|
BRASKAP COMERCIO E INDÚSTRIA S/A |
|
15 3225-3355 |
|
CASA DA QUIMICA |
|
11 4043-2855 |
|
COLORCON DO BRASIL LTDA |
|
11 4617-8669 |
|
COMERCIAL REBESCHINI DE ÁLCOOL |
|
51 3336-1809 |
|
FARMAPLAST IND EMBALAGENS PLÁSTICAS |
|
11 4612-2700 |
|
GENIX INDUSTRIA FARMACEUTICA LTDA |
|
11 2067-5600 |
|
GRAFICA LOTICOMART LTDA |
|
51 3041-3434 |
|
IPIRANGA QUIMICA DIVISÃO EMCA |
|
11 3245-4416 |
|
M CASSAB COM IND LTDA |
|
11 2162-7609 |
|
NILCATEX TEXTIL LTDA. |
|
47 3231-2500 |
|
NORTIS FRMACÊUTICA LTDA |
|
43 3443-2244 |
|
TROMBINI INDUSTRIAL S/A |
|
51 2129-2300 |
|
VALDEQUIMICA PRODUTOS QUIMICOS |
|
11 3721-1077 |
|
VEDAT TAMPAS |
|
51 3217-1177 |
|
WHEATON DO BRASIL INDÚSTRIA COMÉRCIO |
|
51 3217-1177 |
|
FOREIGN
SUPPLIERS: |
COUNTRY: |
|
||
|
FERSINSA GB |
MEXICO |
|
||
|
LA FIDUCIARIA |
ITALY |
|
||
|
LEE PHARMA |
INDIA |
|
||
|
CONCEPT |
|
|
||
|
PAYMENT HISTORY: |
|
16 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 383.292,00 |
|
|
|
AMOUNT OF INVOICES PAID: 101 |
|
TOTAL OF PROMPT PAYMENTS: 99,8% |
|
TOTAL OF DELAYED PAYMENTS: 0,2% |
|
|
|
HIGHEST INVOICE: R$ 26.238,00 |
|
HIGHEST CREDIT: R$ 26.238,00 |
|
|
|
OUTSTANDING
INVOICES DUE WITHIN THE NEXT 30 DAYS: |
|
--------------------------- |
SUPPLIERS: |
INVOICES: |
TOTAL AMOUNT: |
|
DUE WITHIN 30 DAYS |
1 |
1 |
R$ 624,00 |
|
BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD
TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN
TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.11 |
|
UK Pound |
1 |
Rs.102.32 |
|
Euro |
1 |
Rs.81.75 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.